AstraZeneca Pharma India Limited share price
NSE: ASTRAZEN · ISIN INE203A01020
Key numbers
- Market cap
- ₹ 16,263 Cr
- Current price
- ₹ 6,505.00
- 52-week high / low
- ₹ 9,850 / 6,444
- Stock P/E
- 96.2
- Book value
- ₹ 349.1
- Dividend yield
- 0.55%
- ROCE
- 28.7%
- ROE
- 22.8%
- Debt to equity
- 0.13
- Sales growth (3 yrs)
- 31.3%
- Profit growth (3 yrs)
- 23.6%
- 1-year return
- -25.8%
About AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 526 | 559 | 612 | 579 | 683 |
| Operating profit | 81 | 75 | 45 | 61 | 49 |
| Net profit | 56 | 54 | 33 | 45 | 38 |
| EPS (₹) | 22.33 | 21.69 | 13.04 | 17.95 | 15.17 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.